Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

FLT3: receptor and ligand. Biology and potential clinical application.

Shurin MR, Esche C, Lotze MT.

Cytokine Growth Factor Rev. 1998 Mar;9(1):37-48. Review.

PMID:
9720755
2.

Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.

Drexler HG.

Leukemia. 1996 Apr;10(4):588-99. Review.

PMID:
8618433
3.

The effects of human FLT3 ligand on in vitro human megakaryocytopoiesis.

Piacibello W, Garetto L, Sanavio F, Severino A, Fubini L, Stacchini A, Dragonetti G, Aglietta M.

Exp Hematol. 1996 Feb;24(2):340-6.

PMID:
8641363
4.

The flt3 ligand: a hematopoietic stem cell factor whose activities are distinct from steel factor.

Lyman SD, Brasel K, Rousseau AM, Williams DE.

Stem Cells. 1994;12 Suppl 1:99-107; discussion 108-10. Review.

PMID:
7535149
5.

Flt3 ligand bioactivity and pharmacology in neoplasia.

Reber AJ, Ashour AE, Robinson SN, Talmadge JE, Solheim JC.

Curr Drug Targets Immune Endocr Metabol Disord. 2004 Jun;4(2):149-56.

PMID:
15180455
6.

Stem cell factor, but not flt3 ligand, induces differentiation and activation of human mast cells.

Hjertson M, Sundström C, Lyman SD, Nilsson K, Nilsson G.

Exp Hematol. 1996 May;24(6):748-54.

PMID:
8635531
7.

CD135 (Flk2/Flt3) expression by human thymocytes delineates a possible role of FLT3-ligand in T-cell precursor proliferation and differentiation.

Bertho JM, Chapel A, Loilleux S, Frick J, Aigueperse J, Gorin NC, Gourmelon P.

Scand J Immunol. 2000 Jul;52(1):53-61.

8.

Expression of Flt3 and c-kit during growth and maturation of human CD34+CD38- cells.

Xiao M, Oppenlander BK, Plunkett JM, Dooley DC.

Exp Hematol. 1999 May;27(5):916-27.

PMID:
10340408
9.

FLT3: receptor and ligand.

Drexler HG, Quentmeier H.

Growth Factors. 2004 Jun;22(2):71-3. Review.

PMID:
15253381
10.

FLT3 ligand induces the generation of functionally active dendritic cells in mice.

Shurin MR, Pandharipande PP, Zorina TD, Haluszczak C, Subbotin VM, Hunter O, Brumfield A, Storkus WJ, Maraskovsky E, Lotze MT.

Cell Immunol. 1997 Aug 1;179(2):174-84.

PMID:
9268501
11.

Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1alpha(CXCL12)/CXCR4 axis.

Fukuda S, Broxmeyer HE, Pelus LM.

Blood. 2005 Apr 15;105(8):3117-26. Epub 2004 Dec 23.

12.

Flt-3 and its ligand are expressed in neural crest-derived tumors and promote survival and proliferation of their cell lines.

Timeus F, Ricotti E, Crescenzio N, Garelli E, Doria A, Spinelli M, Ramenghi U, Basso G.

Lab Invest. 2001 Jul;81(7):1025-37.

PMID:
11454991
13.

Biology of flt3 ligand and receptor.

Lyman SD.

Int J Hematol. 1995 Aug;62(2):63-73. Review.

PMID:
8590775
14.

Flt3/Flk-2 and c-Kit are not essential for the proliferation of B lymphoid progenitor cells in the bone marrow of the adult mouse.

Ogawa M, Sugawara S, Kunisada T, Sudo T, Hayashi S, Nishikawa S, Kodama H, Nishikawa S.

Exp Hematol. 1998 Jun;26(6):478-88.

PMID:
9620281
15.

Regulatory roles of the ligand for Flk2/Flt3 tyrosine kinase receptor on human hematopoiesis.

Namikawa R, Muench MO, Roncarolo MG.

Stem Cells. 1996 Jul;14(4):388-95. Review.

16.

The roles of FLT3 in hematopoiesis and leukemia.

Gilliland DG, Griffin JD.

Blood. 2002 Sep 1;100(5):1532-42. Review.

17.

Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells.

McKenna HJ, Stocking KL, Miller RE, Brasel K, De Smedt T, Maraskovsky E, Maliszewski CR, Lynch DH, Smith J, Pulendran B, Roux ER, Teepe M, Lyman SD, Peschon JJ.

Blood. 2000 Jun 1;95(11):3489-97.

18.

Biologic effects and potential clinical applications of Flt3 ligand.

Lyman SD.

Curr Opin Hematol. 1998 May;5(3):192-6. Review.

PMID:
9664159
19.

Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia.

O'Farrell AM, Yuen HA, Smolich B, Hannah AL, Louie SG, Hong W, Stopeck AT, Silverman LR, Lancet JE, Karp JE, Albitar M, Cherrington JM, Giles FJ.

Leuk Res. 2004 Jul;28(7):679-89.

PMID:
15158089
20.

The expression of FMS, KIT and FLT3 in hematopoietic malignancies.

Birg F, Rosnet O, Carbuccia N, Birnbaum D.

Leuk Lymphoma. 1994 Apr;13(3-4):223-7. Review.

PMID:
7519507

Supplemental Content

Support Center